Edwards Lifesciences Corporation (EW)
Pre-market:
| Previous close | 85.25 |
| Open | 85.83 |
| Bid | 84.20 x 800 |
| Ask | 0.00 x 1100 |
| Day's range | 84.81 - 86.00 |
| 52-week range | 60.57 - 96.12 |
| Volume | |
| Avg. volume | 3,490,776 |
| Market cap | 51.275B |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | 36.68 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Is Edwards Lifesciences (EW) Outperforming Other Medical Stocks This Year?
Here is how Edwards Lifesciences (EW) and SNDL Inc. (SNDL) have performed compared to their sector so far this year.
- Zacks
Down -10.22% in 4 Weeks, Here's Why You Should You Buy the Dip in Edwards Lifesciences (EW)
The heavy selling pressure might have exhausted for Edwards Lifesciences (EW) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- Insider Monkey
Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call Transcript April 25, 2024 Edwards Lifesciences Corporation beats earnings expectations. Reported EPS is $0.66, expectations were $0.64. Edwards Lifesciences Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to […]
